Chawarski MC - Search Results

1

Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder.

Lyons MS, Chawarski MC, Rothman R, Whiteside L, Cowan E, Richardson LD, Hawk K, Tsui JI, Schwartz RP, O'Connor P, D'Onofrio G, Fiellin DA, Edelman EJ. Lyons MS, et al. Among authors: chawarski mc. J Addict Med. 2023 Mar-Apr 01;17(2):210-214. doi: 10.1097/ADM.0000000000001074. Epub 2022 Sep 27. J Addict Med. 2023. PMID: 36170184 Free PMC article.

2

Plasma concentrations of buprenorphine 24 to 72 hours after dosing.

Chawarski MC, Schottenfeld RS, O'Connor PG, Pakes J. Chawarski MC, et al. Drug Alcohol Depend. 1999 Jun 1;55(1-2):157-63. doi: 10.1016/s0376-8716(98)00192-6. Drug Alcohol Depend. 1999. PMID: 10402160 Free article. Clinical Trial.

3

Thrice-weekly versus daily buprenorphine maintenance.

Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Schottenfeld RS, et al. Biol Psychiatry. 2000 Jun 15;47(12):1072-9. doi: 10.1016/s0006-3223(99)00270-x. Biol Psychiatry. 2000. PMID: 10862807 Free article. Clinical Trial.

4

Methadone maintenance in primary care: a randomized controlled trial.

Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Fiellin DA, et al. JAMA. 2001 Oct 10;286(14):1724-31. doi: 10.1001/jama.286.14.1724. JAMA. 2001. PMID: 11594897 Clinical Trial.

5

Treatment of heroin dependence with buprenorphine in primary care.

Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Fiellin DA, et al. Am J Drug Alcohol Abuse. 2002;28(2):231-41. doi: 10.1081/ada-120002972. Am J Drug Alcohol Abuse. 2002. PMID: 12014814

6

Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care.

Fiellin DA, O'Connor PG, Chawarski M, Schottenfeld RS. Fiellin DA, et al. Am J Addict. 2004;13 Suppl 1:S67-78. doi: 10.1080/10550490490440843. Am J Addict. 2004. PMID: 15204676

7

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Drug Alcohol Depend. 2005 Jul;79(1):113-6. doi: 10.1016/j.drugalcdep.2004.12.008. Drug Alcohol Depend. 2005. PMID: 15943950 Clinical Trial.

8

Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.

Chawarski MC, Moody DE, Pakes J, O'Connor PG, Schottenfeld RS. Chawarski MC, et al. J Subst Abuse Treat. 2005 Dec;29(4):307-12. doi: 10.1016/j.jsat.2005.08.011. J Subst Abuse Treat. 2005. PMID: 16311183 Clinical Trial.

9

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS. Fiellin DA, et al. Among authors: chawarski mc. N Engl J Med. 2006 Jul 27;355(4):365-74. doi: 10.1056/NEJMoa055255. N Engl J Med. 2006. PMID: 16870915 Free article. Clinical Trial.

10

A trial of integrated buprenorphine/naloxone and HIV clinical care.

Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Among authors: chawarski mc. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S184-90. doi: 10.1086/508182. Clin Infect Dis. 2006. PMID: 17109305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters